A report from BusinessWeek from 27 August 2009:
Drug, Biotech Research Spending Hangs Tough
Overall U.S. corporate R&D spending is down 4% since the end of 2007, but some companies have chosen to buck the trend
By Emily Thornton and Frederick Jespersen
[snip]
Corporate America's research spending shrank 4% overall, or $1.9 billion, from the fourth quarter of 2007 through the second quarter of this year, according to data compiled by Capital IQ on 961 U.S. companies. But many health-care companies have boosted their research outlays.
BusinessWeek sought out 25 companies that most aggressively increased their research budgets during the first six months of 2009. Thirteen members of the group, which collectively boosted its spending by $2 billion, were pharmaceutical and biotech companies. Only eight were high-tech outfits, such as Apple (AAPL) and Microsoft (MSFT).
[snip]
Read the full article
Drug, Biotech Research Spending Hangs Tough
Overall U.S. corporate R&D spending is down 4% since the end of 2007, but some companies have chosen to buck the trend
By Emily Thornton and Frederick Jespersen
[snip]
Corporate America's research spending shrank 4% overall, or $1.9 billion, from the fourth quarter of 2007 through the second quarter of this year, according to data compiled by Capital IQ on 961 U.S. companies. But many health-care companies have boosted their research outlays.
BusinessWeek sought out 25 companies that most aggressively increased their research budgets during the first six months of 2009. Thirteen members of the group, which collectively boosted its spending by $2 billion, were pharmaceutical and biotech companies. Only eight were high-tech outfits, such as Apple (AAPL) and Microsoft (MSFT).
[snip]
Read the full article
Comments